本文へ移動
cccskills
無料GitHub で公開

es-assess-transsexualism-icd10

Determines if patient meets ICD-10 criteria for transsexualism. Triggered when a clinician uses ICD-10 for diagnostic purposes in gender identity assessment.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.1 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Assess for transsexualism using ICD-10 criteria

STEP 1 — Gather Information

Collect: patient's expressed desire to live and be accepted as a member of the opposite sex, wish to make body congruent via surgery/hormone treatments; duration of transsexual identity; presence of comorbid mental disorders, genetic conditions, DSD, or chromosomal abnormalities.

STEP 2 — Rule In / Rule Out

Does the patient have a persistent desire to live and be accepted as a member of the opposite sex, accompanied by the wish to make the body as congruent as possible through surgery and hormone treatments?

  • Yes → proceed to Step 3
  • No → rule out transsexualism (does not meet criterion 1)

STEP 3 — Classify or Stratify

Has the transsexual identity been present persistently for at least 2 years?

  • Yes → proceed to Step 4
  • No → rule out transsexualism (does not meet criterion 2)

STEP 4 — Decide

Is the disorder not a symptom of another mental disorder, genetic, DSD, or chromosomal abnormality?

  • Yes → patient meets ICD-10 criteria for transsexualism (F64.0)
  • No → rule out transsexualism (does not meet criterion 3)

Clinical Guardrails / Mimics / Pitfalls

Do not confuse with DSM-5 gender dysphoria; ensure persistence is continuous, not intermittent; rule out body dysmorphic disorder, psychotic disorders, or DSD/chromosomal conditions that may mimic gender incongruence; avoid diagnosing if criteria are met only during transient phases of identity exploration.

Concrete Clinical Example

A 28-year-old assigned male at birth reports a 3‑year history of desiring to live as female, wishes to start hormone therapy and undergo surgery, denies any other mental illness, and has no known DSD or chromosomal abnormality → meets all three ICD-10 criteria for transsexualism.

Source: Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons, Endocrine Society, 2017, doi:10.1210/jc.2017-01658

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する